Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 5,189 | N/A | N/A |
| Receivables | 1,152 | N/A | N/A |
| Other current assets | 23 | 0 | 0 |
| TOTAL | $6,908 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 211 | N/A | N/A |
| TOTAL | $211 | $N/A | $N/A |
| Total Assets | $7,119 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,003 | 0 | 0 |
| Accrued Expenses | 994 | N/A | N/A |
| Other current liabilities | 253 | N/A | N/A |
| TOTAL | $3,250 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 443 | N/A | N/A |
| Other Non-Current Liabilities | 16,240 | 0 | 0 |
| TOTAL | $16,683 | $N/A | $N/A |
| Total Liabilities | $19,933 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | N/A | N/A |
| Retained earnings | -68,220 | N/A | N/A |
| Other shareholders' equity | 55,183 | 0 | 0 |
| TOTAL | $-12,814 | $N/A | $N/A |
| Total Liabilities And Equity | $7,119 | $0 | $0 |